Valuation: EUROAPI

Market Cap 71.65M 80.52M 66.31M 60.41M 114M 7.65B 116M 798M 313M 3.99B 302M 296M 12.69B P/E 2026 *
-0.57x
P/E 2027 * -1.33x
Enterprise Value 127M 143M 117M 107M 202M 13.54B 205M 1.41B 554M 7.06B 535M 524M 22.47B EV / Sales 2026 *
0.17x
EV / Sales 2027 * 0.24x
Free-Float
64.75%
Yield 2026 *
-
Yield 2027 * -
1 day+1.63%
1 week-2.85%
Current month+3.59%
1 month-12.18%
3 months-41.68%
6 months-43.27%
Current year-66.96%
1 week 0.71
Extreme 0.714
0.78
1 month 0.71
Extreme 0.713
0.86
Current year 0.71
Extreme 0.713
2.28
1 year 0.71
Extreme 0.713
3.39
3 years 0.71
Extreme 0.713
7.02
5 years 0.71
Extreme 0.713
19.02
10 years 0.71
Extreme 0.713
19.02
Manager TitleAgeSince
Chief Executive Officer - 08/12/2024
Director of Finance/CFO - 16/10/2024
Compliance Officer - 26/11/2023
Director TitleAgeSince
Director/Board Member 62 05/05/2022
Director/Board Member - 05/05/2022
Chairman 57 08/12/2024
Date Insider Type Main position Quantity % Market Cap. Importance
01/06/23 Buy

Chief Financial Officer

617 0.0007%
01/06/23 Buy

Chief Financial Officer

620 0.0007%
01/06/23 Buy

Chief Financial Officer

617 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
+1.63%-2.85%-76.65%-84.93% 80.6M
+0.43%+6.59%+53.41%+103.85% 1,120B
+0.90%-2.25%+33.02%+62.23% 616B
+0.71%+3.24%+25.81%+93.86% 504B
-0.13%+5.98%+32.91%+50.39% 367B
+0.52%+0.24%+73.92%+40.15% 360B
-0.95%+4.70%+19.51%+43.00% 288B
-1.98%+3.73%-0.86%+13.43% 258B
-0.35%+4.25%+46.21%+50.76% 234B
-0.75%+3.32%+32.53%+97.21% 194B
Average +0.00%+2.97%+23.98%+46.99% 394.1B
Weighted average by Cap. +0.13%+3.83%+39.18%+71.43%

Financials

2026 *2027 *
Net sales 748M 841M 693M 631M 1.19B 79.84B 1.21B 8.33B 3.27B 41.64B 3.16B 3.09B 133B 748M 840M 692M 630M 1.19B 79.77B 1.21B 8.33B 3.27B 41.6B 3.15B 3.09B 132B
Net income -125M -140M -115M -105M -198M -13.29B -201M -1.39B -544M -6.93B -525M -514M -22.05B -53.63M -60.28M -49.63M -45.22M -85.21M -5.72B -86.72M -597M -234M -2.98B -226M -221M -9.5B
Net Debt 55.24M 62.08M 51.12M 46.57M 87.76M 5.89B 89.32M 615M 241M 3.07B 233M 228M 9.78B 105M 118M 97.02M 88.39M 167M 11.19B 170M 1.17B 458M 5.83B 442M 433M 18.57B
Projected Income Statement - Annual - EUROAPI
Logo EUROAPI
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 5 production sites located in France (2), Germany, Italy and Hungary.
Employees
2,961
Date Price Change Volume
16/10/26 €0.7500 +1.63% 180,262
15/10/26 €0.7380 +1.10% 51,859
14/10/26 €0.7300 +2.24% 199,355
13/10/26 €0.7140 -7.51% 428,651
12/10/26 €0.7720 0.00% 34,456
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - EUROAPI
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
4
Last Close Price
0.7500EUR
Average target price
1.000EUR
Spread / Average Target
+33.33%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - EUROAPI
  1. Stock Market
  2. Stocks
  3. EAPI Stock